Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Gattuso

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Oncology Reports|December 5, 2003
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaAlessandro Morabito, Massimo Fanelli, Guido Carillio, et al.
Critical Reviews in Oncology/Hematology|December 13, 2005
Is tailored therapy feasible in oncology?Giampietro Gasparini, Raffaele Longo, Francesco Torino, et al.
Journal of Gastrointestinal Cancer|January 29, 2013
Atypical multiple ileum metastases of renal cell carcinomaRaffaele Longo, Domenico Gattuso, Roberto Luchetti, et al.
Recenti Progressi in Medicina|December 20, 2002
[Innovative treatment in oncology]Barbara Capaccetti, Paola Bonginelli, Roberta Sarmiento, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Primary nongestational choriocarcinoma of the uterine cervixRaffaele Longo, Francesco Battaglia, Domenico Gattuso, et al.
Clinical Breast Cancer|March 15, 2003
Prognostic and predictive indicators in operable breast cancerAlessandro Morabito, Elena Magnani, Massimo Gion, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Thalidomide: a new anticancer drug?Massimo Fanelli, Roberta Sarmiento, Domenico Gattuso, et al.
The Oncologist|October 27, 2005
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancerGiampietro Gasparini, Domenico Gattuso, Alessandro Morabito, et al.
International Journal of Gastrointestinal Cancer|February 10, 2007
Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical courseRaffaele Longo, Alessandro Morabito, Guido Carillio, et al.
Breast Cancer Research and Treatment|March 4, 2003
The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II studyAlessandro Morabito, Gianfranco Filippelli, Sergio Palmeri, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Oncology Reports|December 5, 2003
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaAlessandro Morabito, Massimo Fanelli, Guido Carillio, et al.
Critical Reviews in Oncology/Hematology|December 13, 2005
Is tailored therapy feasible in oncology?Giampietro Gasparini, Raffaele Longo, Francesco Torino, et al.
Journal of Gastrointestinal Cancer|January 29, 2013
Atypical multiple ileum metastases of renal cell carcinomaRaffaele Longo, Domenico Gattuso, Roberto Luchetti, et al.
Recenti Progressi in Medicina|December 20, 2002
[Innovative treatment in oncology]Barbara Capaccetti, Paola Bonginelli, Roberta Sarmiento, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Primary nongestational choriocarcinoma of the uterine cervixRaffaele Longo, Francesco Battaglia, Domenico Gattuso, et al.
Clinical Breast Cancer|March 15, 2003
Prognostic and predictive indicators in operable breast cancerAlessandro Morabito, Elena Magnani, Massimo Gion, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Thalidomide: a new anticancer drug?Massimo Fanelli, Roberta Sarmiento, Domenico Gattuso, et al.
The Oncologist|October 27, 2005
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancerGiampietro Gasparini, Domenico Gattuso, Alessandro Morabito, et al.
International Journal of Gastrointestinal Cancer|February 10, 2007
Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical courseRaffaele Longo, Alessandro Morabito, Guido Carillio, et al.
Breast Cancer Research and Treatment|March 4, 2003
The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II studyAlessandro Morabito, Gianfranco Filippelli, Sergio Palmeri, et al.
Pageof 2